3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
47
Head & Neck
7
Thoracic
5
Genitourinary
5
Breast
5
Endocrine
4
Tumor-Agnostic
2
Gynecologic
2
Sarcoma
1
NET
1
Lymphoid
1
Conditions
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Interventions
lutetium Lu 177 dotatate
2
Lutetium-177
2
Liquid Biopsy
2
Endoscopic Mucosal Resection
2
Data Collection
2
pentetreotide
1
fluorodopa F 18
1
copper dotatate CU-64
1
Yttrium-90
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Single Photon Emission Computed Tomography Computed Tomography
1
Serum Albumin
1
Robotic Surgical Procedures
1
Resveratrol
1
Respiratory Therapy
1
Referral and Consultation
1
Radiofrequency Ablation
1
Quality of Life
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Palliative Care
1
Octreotide
1
Nutrition Assessment
1
Needles
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Drug Therapy
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Radiofrequency Ablation
×
NET
×
Clear all
NCT05243082
2023-03-30
ERFA-PNET
Oslo University Hospital
Phase NA
Recruiting
20 enrolled